CELC
Celcuity LLC
NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY
$121.35
+1.97% today
Updated 2026-04-30
Market cap
$5.80B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$10 – $129
Volume
0.7M
Celcuity LLC (CELC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.30M | $6.06M | $31.97M | $26.03M | $20.28M | $12.96M | $85.91M | $175.70M | $191.22M | $245.12M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — |
| Current assets | $5.12M | $5.91M | $24.48M | $25.22M | $19.25M | $12.17M | $85.35M | $175.16M | $190.59M | $244.57M |
| Total liabilities | $283604.00 | $445359.00 | $578053.00 | $682210.00 | $983229.00 | $1.25M | $17.20M | $41.93M | $51.45M | $129.50M |
| Current liabilities | $283604.00 | $445359.00 | $578053.00 | $662332.00 | $911327.00 | $1.19M | $2.51M | $6.88M | $14.19M | $31.72M |
| Long-term debt | — | — | $0.00 | — | — | — | $14.63M | $34.98M | $37.04M | $97.73M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-5.02M | $-8.33M | $-2.01M | $-9.49M | $-16.85M | $-26.32M | $-55.93M | $-96.30M | $-160.08M | $-271.86M |
| Accounts receivable | — | — | — | — | $190000.00 | $190000.00 | $298764.00 | $203665.00 | $805882.00 | $1.60M |
| Inventory | — | — | $0.00 | — | $-190000.00 | $-190000.00 | $-298764.00 | $-203665.00 | — | $-8.63M |
| Goodwill | — | — | $0.00 | — | — | — | — | — | — | — |